Nabriva Therapeutics (NBRVF) Q1 2020 Earnings

11MayExpected
Q2 2019
Q3 2019
Q4 2019
Q1 2020
-0.34
-0.31
-0.27
-0.24

Details

Expected EPS
-0.26
Actual EPS
-0.25
Surprise EPS
0.01
Surprise Percent
+3.85%

Description

Nabriva Therapeutics (NBRVF) has reported earnings of -0.25 per share for Q1 2020.

0 Comments

Share your thoughts